EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Atheroprotective role of vinpocetine: an old drug with new indication

Mohammed H Abu-Alghayth, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Mostafa M Bahaa, Mohammed Afifi, Ammar Al-Farga, Eman Wahsh, Gaber El-Saber Batiha

Inflammopharmacology · 2024

DOI: 10.1007/s10787-024-01529-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Mohammed H Abu-Alghayth und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 255, 67714, Bisha, Saudi Arabia. Hauptthemen laut MEDLINE: Vinca Alkaloids, Atherosclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bisha, Private Universität Witten/Herdecke gGmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial dysfunction is considered one of the main causes of atherosclerosis and elevated blood pressure. Atherosclerosis (AS) formation is enhanced by different mechanisms including cytokine generation, vascular smooth muscle cell proliferation, and migration. One of the recent treatment toward endothelial dysfunction is vinpocetine (VPN). VPN is an ethyl apovincaminate used in the management of different cerebrovascular disorders and endothelial dysfunction through inhibition of atherosclerosis formation. VPN is a potent inhibitor of phosphodiesterase enzyme 1 (PDE1) as well it has anti-inflammatory and antioxidant effects through inhibition of the expression of nuclear factor kappa B (NF- κ B). VPN has been shown to be effective against development and progression of AS. However, the underlying molecular mechanism was not fully clarified. Consequently, objective of the present narrative review was to clarify the mechanistic role of VPN in AS. Most of pro-inflammatory cytokines released from macrophages are inhibited by the action of VPN via NF- κ B-dependent mechanism. VPN blocks monocyte adhesion and migration by inhibiting the expression of pro-inflammatory cytokines. As well, VPN is effective in reducing oxidative stress, a cornerstone in the pathogenesis of AS, through inhibition of NF- κ B and PDE1. VPN promotes plaque stability and prevent erosion and rupture of atherosclerotic plaque. In conclusion, VPN through mitigation of inflammatory and oxidative stress with plaque stability effects could be effective agent in the management of endothelial dysfunction through inhibition of atherosclerosis mediators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vinca AlkaloidsAtherosclerosisHumansAnimalsOxidative StressNF-kappa BAnti-Inflammatory AgentsCytokinesAntioxidantsEndothelium, Vascular

Stichwörter der Autor:innen

AtherosclerosisEndothelial dysfunctionPro-inflammatory cytokinesReactive oxygen speciesVinpocetine

Substanzen

vinpocetineVinca AlkaloidsNF-kappa BAnti-Inflammatory AgentsCytokinesAntioxidants

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 255, 67714, Bisha, Saudi Arabia.
  • Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
  • University Centre for Research and Development, Chandigarh University, Chandigarh-Ludhiana highway, Mohali, Punjab, India.
  • Department of Research and Development, Funogen, 11741, Athens, Greece.
  • Department of Research and Development, AFNP Med, 1030, Vienna, Austria.
  • Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW, 2770, Australia.

Förderung

  • University of Bisha
  • Private Universität Witten/Herdecke gGmbH

Zitieren

APA

Abu-Alghayth, M. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A., Papadakis, M., Bahaa, M. M., Afifi, M., Al-Farga, A., Wahsh, E., & Batiha, G. E. (2024). Atheroprotective role of vinpocetine: an old drug with new indication. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01529-5

Vancouver

Abu-Alghayth MH, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Bahaa MM, et al. Atheroprotective role of vinpocetine: an old drug with new indication. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01529-5

BibTeX
@article{AbuAlghayth2024,
  author = {Abu-Alghayth, Mohammed H and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Alexiou, Athanasios and Papadakis, Marios and Bahaa, Mostafa M and Afifi, Mohammed and Al-Farga, Ammar and Wahsh, Eman and Batiha, Gaber El-Saber},
  title = {Atheroprotective role of vinpocetine: an old drug with new indication},
  journal = {Inflammopharmacology},
  year = {2024},
  doi = {10.1007/s10787-024-01529-5}
}
Kostenlos starten →